July 11, 2022Open Access

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

CLDN18.2-positive GC displayed unique immune-microenvironmental characteristics, which is of great significance for the development of CLDN18.2-targeted therapies. However, the impact of CLDN18.2-related microenvironmental features on prognosis requires further investigation.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Jia et al. (Mon,) studied this question.

synapsesocial.com/papers/69df43ff44b0122c4f7a12f5 https://doi.org/https://doi.org/10.1186/s12916-022-02421-1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer2020 · 54 citations
2Role of claudins in tumorigenesis2005 · 232 citations
3Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer2017 · 637 citations
4Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment2021 · 48 citations
51372O CLDN 18.2-targeted CAR-T cell therapy in patients with cancers of the digestive system2021 · 23 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo